Eight hospitals in China will participate in the study, which aims to decrease the incidence of severe hyperbilirubinemia.
Through a prospective cohort study of healthy term and near-term infants, the study tries to truly reflect the epidemiology, intervention status, and outcomes of neonatal hyperbilirubinemia and the cost. Hopefully, by improving the quality of management of neonatal jaundice,we can explore and obtain a healthy term and near-term jaundice management model suitable for China's national condition, which can eventually reduce the incidence rate of neonatal severe hyperbilirubinemia and bilirubin encephalopathy.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Enrollment
20,000
During the Intervention phase and Sustainability phase ,The hospitals will receive training of multiple evidence based quality improvement methods.
Nanjing Maternity and Child Health Care Hospital
Nanjing, Jiangsu, China
The incidence of bilirubin encephalopathy
Time frame: 18 months
The incidence of severe hyperbilirubinemia
Severe hyperbilirubinemia:total serum bilirubin more than 20mg/dL
Time frame: 18 months
The rate of lost to follow-up
The rate of lost to follow-up for jaundice after discharge from well-baby nursery
Time frame: 18 months
The incidence of adverse neurological outcomes in patients with severe hyperbilirubinemia
Patients with severe hyperbilirubinemia from 11 hospitals will be followed to investigate their neurological outcomes until 24 months after birth
Time frame: 42 months
Medical costs in patients with severe hyperbilirubinemia
To compare the medical costs in patients with severe hyperbilirubinemia from 3 phases of quality improvement.
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.